|
Hydrops Fetalis
|
C13.703.277.060.480 |
|
|
Erythroblastosis, Fetal
|
C13.703.277.060 |
|
|
Theranostic Nanomedicine
|
H01.603.600.500 |
|
|
Pain, Procedural
|
D000073818 |
[Pain associated with examination, treatment or procedures.
] |
|
Palate
|
A14.549.617 |
|
|
Receptors, Serotonin
|
D12.776.543.750.695.800 |
|
|
Calcitonin Gene-Related Peptide Receptor Antagonists
|
D27.505.519.270 |
|
|
CCR5 Receptor Antagonists
|
D27.505.519.275 |
|
|
Pierre Robin Syndrome
|
C16.131.621.207.540.460.606 |
|
|
Infarction, Middle Cerebral Artery
|
C23.550.717.489.250.200.450 |
|
|
Zonisamide
|
D02.886.590.700.987 |
|
|
Oxocins
|
D02.355.291.866 |
|
|
Journalism, Medical
|
L01.737.498.550 |
|
|
Risedronic Acid
|
D02.705.429.500.872 |
|
|
Bladder Exstrophy
|
C13.351.875.132 |
|
|
Mandatory Programs
|
N04.452.521 |
|
|
Veterans Health Services
|
N04.452.524 |
|
|
Chromosomes, Human, X
|
A11.284.187.520.300.325.680 |
|
|
Chromosomes, Human, 6-12 and X
|
A11.284.187.520.300.325 |
|
|
Workforce
|
N04.452.525 |
|
